News for hackers. Stuff that matters.

A comment on Amygdala connectivity predicts ketamine treatment response among patients (cont). Parent comment

Re:Amygdala connectivity predicts ketamine treatment respons... by cmrdporcupine on Monday November 28, 2022 @07:07PM (#33781762)
"Although Axsome has not yet announced a price, it’s anticipated that it will be a relatively expensive product compared with generic SSRIs and SNRIs, which are very well-established on the MDD market. With a comparatively high expected price, Auvelity may see its use restricted by payers to second and later lines of therapy."

This is insane gouging, as you could literally make it yourself by getting a prescription for generic bupoprion and some store-bought cough medicine.

[ Parent | on HN ]

There are no comments on this comment yet.